Barbara Ann Karmanos Cancer Institute
08/12/2025 | Press release | Archived content
IN THE NEWS - Hodgkin Lymphoma: Survival Rate by Stage Explained
August 12, 2025
Patient Power
Hodgkin lymphoma is a treatable cancer, and many patients diagnosed with it will be cured. Though stage does matter when it comes to prognosis, Dipenkumar Modi, M.D., hematologist and medical oncologist, and member of the Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams at Karmanos, shared some promising new therapies and immunotherapies that have helped improve patient outcomes.
Read the article here.
Barbara Ann Karmanos Cancer Institute published this content on August 12, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 09, 2025 at 12:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]